- GSK +0.16%
Search results
- 41.08Add to watchlist+0.07 (+0.16%)As of Fri. Aug 16, 2024 10:06 AM EDT · Nasdaq Real Time Price (USD) · Market open
- Open41.07High41.12Low41.02
- Mkt Cap83.78BP/E (TTM)14.17Div & Yield1.53 & 3.71%
- Prev. Close41.0152 Wk. Low33.6752 Wk. High45.93
What analysts are sayingTop storiesGSK plc (GSK): Why Are Hedge Funds Bullish on This Undervalued UK Stock Now?Yahoo Finance · 6 days agoBritish Pharma Giant GSK's Blockbuster Shingles And Respiratory Syncytial Virus Vaccine Q2 Sales Miss Expectations, ...Yahoo Finance · 2 weeks agoRelated stocks
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
Home | GSK US. GSK delivers second quarter 2024 results . Quarterly results. Behind the science US edition. Thinking outside the box: a personal journey. MacRae shares his story of growing up biracial in the US and the impact it has had on his career today. Inclusive leadership hits different.
From quarterly updates to key announcements, here you can access GSK investor-related information.
Meet our people. We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
Find the latest GSK plc (GSK.L) stock quote, history, news and other vital information to help you with your stock trading and investing.
Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Company. At a glance. Getting Ahead Together means preventing disease as well as treating it. Globally, our portfolio spans vaccines, specialty and general medicines, with R&D focused on science of the immune system, human genetics and advanced technologies. In 2023, US GSK's sales reached $19.6bn.
Stock analysis for GSK PLC (GSK:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.